In Lesotho's 2024 national health survey, 38.9% of 3,250 women of reproductive age had been screened for cervical cancer. Screening was more common in women aged 20 and over, with schooling and with more exposure to media.
Published as "Determinants of cervical cancer screening uptake in Lesotho: evidence from 2024 Demographic and Health Survey data". A secondary analysis of the 2024 Lesotho Demographic and Health Survey using a multilevel logistic regression model, by authors at the University of Gondar in Ethiopia.
About four in ten women of reproductive age in Lesotho report having been screened, in the country where cervical cancer is estimated to be the commonest cancer.
Acceptance of the vaccine is high, and the gap is in reaching girls who are not in school and in record keeping. The authors suggest moving to routine delivery in primary care and the single-dose schedule WHO recommends.
Medical fees were a small part of what screening cost these women (4%); the rest was indirect costs and lost productivity, and nine in ten had to make a second trip for results. The authors argue that patient costs belong in screening policy and economic evaluations.
Shares What cervical cancer screening costs patients at the Senkatana centre, Lesotho, Ministry of Health, Lesotho.
Shares What cervical cancer screening costs patients at the Senkatana centre, Lesotho, Ministry of Health, Lesotho.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/